Search
Confirm
Close

ABOUT VIWIT

With high-quality products and services, we continue to create more value for our customers, employees, shareholders and society, and contribute our talents and efforts to a healthier and better life

COMPANY PROFILE

Viwit pharmaceutical is a medical and health enterprise that integrates research and development, production and marketing based on technological innovation. It is committed to building a platform for biomedical innovation and innovation and a pharmaceutical and health industry chain system that serves the clinical needs of the public.

VIWIT pharmaceutical was founded in 2006, from the beginning of research and development, through Viwit people tireless hard work, from the initial chiral borane products on the basis of the continuous extension of the industrial chain, the current business areas include chemical drugs, biological products, bulk drugs and borane products. Viwit pharmaceutical now has 2 integrated product research and development centers, 3 cGMP production bases (see the development history of Viwit pharmaceutical for details), and its marketing network is distributed in China, the United States, Canada, the European Union and other regions. The overall layout of Viwit medicine is still expanding in the development process of the industrial chain system.

威智医药

PRODUCT INTRODUCTION

We are committed to developing into a global leading medical and health enterprise based on the overall competitive advantage of the industrial chain and based on technological innovation

HOT PRODUCTS

Adhere to customer demand as the center, build core competitiveness, and strive to provide people with better and better quality health products and services

产品名称

Puerarin Injection 5ml:0.25g

[Drug Name] Generic Name: Puerarin Injection<br/>
English name:Puerarin Injection<br/>
Chinese Pinyin:Gegensu Zhusheye <br/>
【specification】 (1)5mL:0.25g <br/>(2)8mL:0.4g<br/>
[Indications] It is used to assist in the treatment of coronary heart disease, angina pectoris, myocardial infarction, retinal artery and vein occlusion, and sudden deafness. <br/>
产品名称

Puerarin Injection 8ml:0.4g

【Drug Name】 Common Name: Puerarin Injection<br/>
English name:Puerarin Injection<br/>
Chinese Pinyin:Gegensu Zhusheye<br/>
【specification】(1)5mL:0.25g  (2)8mL:0.4g <br/>
[Indications] It is used to assist in the treatment of coronary heart disease, angina pectoris, myocardial infarction, retinal artery and vein occlusion, and sudden deafness. <br/>
产品名称

Propyl gallate injection 5ml:60mg

【Drug name】 Common name: Propyl gallate injection<br/>
Product Name: Encyclopedia Locke<br/>
English name:Propylgallate Injection<br/>
Chinese Pinyin:Beibingzhi Zhusheye<br/>
【specification】(1)5ml:60mg  (2)10ml:120mg <br/>
[Indications] It is used to prevent and treat cerebral thrombosis, coronary heart disease and complications after surgery-thrombosis deep phlebitis.<br/>
产品名称

Clindamycin Phosphate Injection 2ml:0.3g

[Drug Name] Generic Name: Clindamycin Phosphate Injection<br/>
English name:Clindamycin Phosphate Injection<br/>
Chinese Pinyin:Kelinmeisu Linsuanzhi Zhusheye <br/>
【specification】(1)2mL:0.3g  (According to C18H33ClN2O5S)  <br/>
   (2)4mL:0.6g  (按C18H33ClN2O5S计) <br/>
【Indications】  1. This product is suitable for the following infectious diseases caused by Gram-positive bacteria:<br/>
   (1)Tonsillitis, suppurative otitis media, sinusitis, etc.<br/>
   (2)Acute bronchitis, acute exacerbation of chronic bronchitis, pneumonia, lung abscess and bronchiectasis with infection.<br/>

INNOVATION 

& cooperation platform

CDMO

Viwit pharmaceutical API factories are built in accordance with cGMP standards and requirements, with API and advanced intermediate r & d department, production  ...

威智医药

Project Cooperation

To provide the whole industrial chain from raw materials to finished drugs research and development and industrialization cooperation

威智医药
威智医药

Resource Sharing

Provide marketing, fund raising and other resources cooperation

In-/Out-Licensing

Viwit is committed to developing and delivering innovative, valuable medicines to our customers and is willing to assist our partners in bringing high-quality products to the global market. Viwit is highly interested in collaborative opportunities

威智医药

NEWS CENTER

Make due contribution to the development of the industry and society, and strive to become the pacesetter and pioneer of the industry.

2020

01 -24

In September 2018, Viwit pharmaceutical's API plant in tengzhou, shandong province, received a five-day GMP audit from health Canada. In the end, Viwit pharmaceutical successfully completed the GMP inspection of health Canada and achieved excellent results. Any regulatory review is a challenge, but it is also a great opportunity to demonstrate competence. Viwit pharmaceutical has always adhered to the concept of conforming to cGMP standards and committed to follow a high standard of quality management system. The successful completion of the on-site inspection by health Canada is another milestone in the process of becoming a world leading pharmaceutical and health company. Viwit pharmaceutical will continue to follow the cGMP standards for each operating procedure, to provide the market with safer, high-quality products.

2020

01 -24

Viwit pharmaceutical participated in CPhI China 2019, booth: W2B28 CPhI China 2019 will be held in Shanghai new international expo center from June 18 to 20, 2019. If you would like to make an appointment in advance, please send an email to service@viwit.com.

2020

01 -24

Organized and unorganized gas detection reports, the specific results are as follows:Environmental monitoring plan of shandong Viwit pharmaceutical industry co., LTD. 2019. Rar.Unorganized waste gas, organized waste gas, wastewater, groundwater, noise first quarter 2019 test report. Doc.Unorganized exhaust for the second quarter of 2019. Doc

2020

01 -24

CPhI India 2018 will take place on Dec. 12 - Dec. 14, 2018 at India Expo Center, India. Please visit us on CPhI India 2018, Booth No. 4.H15. If you would like to make an appointment, please send an e-mail to service@viwit.com.

2020

01 -24

CPhI China 2018 will be held in Shanghai new international expo center from June 20 to 22, 2018. Welcome to our booth, booth number: W2A09. If you would like to make an appointment in advance, please send an email to service@viwit.com.